News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe

|Videos|November 10, 2022

Challenges Associated With Insomnia Treatments

Author(s)Charlene Gamadelo, MD

Charlene Gamadelo, MD, describes the different categories of FDA approved treatments for insomnia along with challenges associated with these treatments.

Episodes in this series

EP. 1 Overview of Insomnia

EP. 1 Overview of Insomnia

EP. 2 Insomnia in Female Patients

EP. 2 Insomnia in Female Patients

EP. 3 Quality of Life and Patient Communication Regarding Insomnia

EP. 3 Quality of Life and Patient Communication Regarding Insomnia

EP. 4 Managing Female Patients With Insomnia

EP. 4 Managing Female Patients With Insomnia

EP. 5 Approach to Treating Female Patients With Insomnia

EP. 5 Approach to Treating Female Patients With Insomnia

EP. 6 Challenges Associated With Insomnia Treatments

EP. 6 Challenges Associated With Insomnia Treatments

EP. 7 Insomnia Treatment: DORAs

EP. 7 Insomnia Treatment: DORAs

EP. 8 Insomnia Treatment Selection: DORA

EP. 8 Insomnia Treatment Selection: DORA

Newsletter

Keep your finger on the pulse of neurology—subscribe to NeurologyLive for expert interviews, new data, and breakthrough treatment updates.

Related Content

Excessive Daytime Sleepiness Affects Over 70% of Brazilian Adolescents, Tied to Depression, Smartphone Addiction, Diet

ByIsabella Ciccone, MPH

September 7th 2026

uniQure Submits BLA for Gene Therapy in HD, AAN, AHS Issue Updated Guideline on Migraine Prevention, CTE Prevalence, Brain Donation Findings in Former NFL Players

ByNeurologyLive® Staff

September 5th 2026

FDA Action Update, August 2026: Approvals, Clearances, and Designations

ByIsabella Ciccone, MPH

September 3rd 2026

Overviewing First-Ever Platform Trial for Progressive Supranuclear Palsy: Julio Rojas, MD, PhD

ByJulio Rojas, MD, PhD

September 2nd 2026

FDA Action Update, Week of August 23, 2026: Authorization, Clinical Hold, and Clearance

ByIsabella Ciccone, MPH

August 30th 2026

Latest CME

2026 Carolina Neuromuscular Disease Summit

In-Person + Virtual Event

2026 Carolina Neuromuscular Disease Summit

September 19-20, 2026

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Rewiring Recovery: Evidence-Based Approaches to Managing Chronic Inflammatory Demyelinating Polyneuropathy

Karissa Gable, MD

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Unlocking the Future of Glioma Care: Integrating Recent Advances to Personalize Treatment

Vinay K. Puduvalli, MD; Manmeet Ahluwalia, MD, MBA, FASCO; Girish Dhall, MD

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

From Clue to Care: Rapid Recognition and Coordinated Management of Paraneoplastic LEMS in SCLC

Millie Das, MD; Wade Iams, MD, MSCI; Ruham Nasany, MD

Collaborating Across the Continuum™: Integrating Novel Therapies Into Multidisciplinary Treatment Plans for Generalized Myasthenia Gravis

Collaborating Across the Continuum™: Integrating Novel Therapies Into Multidisciplinary Treatment Plans for Generalized Myasthenia Gravis

Abigail Schwaede, MD; Alexis Lizarraga, MD, MS

Community Collab™: Identifying the Role of Complement Inhibitors in the Management of Generalized Myasthenia Gravis

Community Collab™: Identifying the Role of Complement Inhibitors in the Management of Generalized Myasthenia Gravis

James F. Howard Jr, MD, FAAN; Tuan Vu, MD

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

Community Collab: The Evolving Role of FcRN Inhibitors in the Management of Generalized Myasthenia Gravis (gMG)

James F. Howard Jr, MD, FAAN; Tuan Vu, MD

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

From Suspicion to Stabilization: Early Recognition and Treatment of Paraneoplastic LEMS

Charu Aggarwal, MD, MPH, FASCO; Erminia Massarelli, MD, PhD, MS; Ruham Nasany, MD

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

uniQure Submits BLA for Gene Therapy in HD, AAN, AHS Issue Updated Guideline on Migraine Prevention, CTE Prevalence, Brain Donation Findings in Former NFL Players

FDA Action Update, August 2026: Approvals, Clearances, and Designations

Phase 4 Study Highlights Valbenazine's Positive Impact on Patient-Reported Quality of Life, Daily Functioning in Tardive Dyskinesia

Study Shows DMTs Associated With Higher Risk of Gynecologic Complications in Women With MS

FDA Approves Zilganersen, First Treatment for Alexander Disease